Thomas Jefferson University researchers developed an AutoML model that distinguishes pituitary macroadenomas from parasellar meningiomas on MRI with over 97% accuracy.
Key Details
- 1AutoML model trained to classify pituitary macroadenomas vs. parasellar meningiomas on preoperative MRI.
- 2Achieved 97.55% overall accuracy, with sensitivities of 97% (macroadenoma) and 98.41% (meningioma), and specificities of 98.96% and 95.53%, respectively.
- 3External validation conducted on 959 additional MRI images.
- 4Model allows different confidence thresholds, aiding both community screening and tertiary centers.
- 5First reported use of AutoML for this specific neuro-oncology imaging task.
- 6The study published in Otolaryngology–Head and Neck Surgery (Dec 2025); presented at AAO-HNSF 2025.
Why It Matters
Accurate, non-invasive differentiation of similar-appearing benign brain tumors using MRI can improve preoperative planning, reduce surgical risks, and ensure patients receive optimal treatment. This demonstrates AutoML's potential to streamline diagnostic AI development and deployment in neuro-radiology.
Source
EurekAlert
Related News
•EurekAlert
UVA's $4M NIH Grant Backs AI to Optimize Cardiac MRI Therapies
UVA secures $4 million NIH funding to develop GenStrain, an AI model using MRI data to personalize cardiac pacing therapies.
•EurekAlert
Machine Learning Models Predict Cancer Risk with Routine Health Data
Researchers developed machine learning models using routinely collected health data to predict individual risk for 20 common cancers, outperforming traditional methods for several cancer types.
•EurekAlert
Duke Receives $25M to Lead National Trustworthy AI Hub for Dementia and Aging
Duke University has launched a $25 million national center to make AI for aging and dementia clinically robust and trustworthy.